HomeQuestion
How do you decide between administering or deferring upstream P2Y12 inhibitor treatment until patient is in the lab for NSTEMI or STEMI cases with unknown coronary anatomy?
2 Answers
Mednet Member
Cardiology · University Of California San Francisco Medical Center At Parnassus
Unless you are using clopidogrel there’s no need to consider upstream use in STEMI. In NSTEMI, you can use heparin/lovenox or a P2Y12 no need for both.
If you don’t know the anatomy you’re gambling to give upstream P2Y12.
In ACS administration of a P2Y12 inhibitor before assessment of coronary anato...